» Articles » PMID: 19138989

Multiple Aberrations of Chromosome 3p Detected in Oral Premalignant Lesions

Overview
Specialty Oncology
Date 2009 Jan 14
PMID 19138989
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The study of oral premalignant lesions (OPL) is crucial to the identification of initiating genetic events in oral cancer. However, these lesions are minute in size, making it a challenge to recover sufficient DNA from microdissected cells for comprehensive genomic analysis. As a step toward identifying genetic aberrations associated with oral cancer progression, we used tiling-path array comparative genomic hybridization to compare alterations on chromosome 3p for 71 OPLs against 23 oral squamous cell carcinomas. 3p was chosen because although it is frequently altered in oral cancers and has been associated with progression risk, its alteration status has only been evaluated at a small number of loci in OPLs. We identified six recurrent losses in this region that were shared between high-grade dysplasias and oral squamous cell carcinomas, including a 2.89-Mbp deletion spanning the FHIT gene (previously implicated in oral cancer progression). When the alteration status for these six regions was examined in 24 low-grade dysplasias with known progression outcome, we observed that they occurred at a significantly higher frequency in low-grade dysplasias that later progressed to later-stage disease (P < 0.003). Moreover, parallel analysis of all profiled tissues showed that the extent of overall genomic alteration at 3p increased with histologic stage. This first high-resolution analysis of chromosome arm 3p in OPLs represents a significant step toward predicting progression risk in early preinvasive disease and provides a keen example of how genomic instability escalates with progression to invasive cancer.

Citing Articles

Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment.

Saab S, Zalzale H, Rahal Z, Khalifeh Y, Sinjab A, Kadara H Front Immunol. 2020; 11:159.

PMID: 32117295 PMC: 7026250. DOI: 10.3389/fimmu.2020.00159.


DNA aneuploidy and tissue architecture in oral potentially malignant disorders with epithelial dysplasia assessed by a 10 locus FISH panel.

Zaini Z, Neat M, Stokes A, Tavassoli M, Odell E Oncol Rep. 2020; 43(3):877-885.

PMID: 32020221 PMC: 7041104. DOI: 10.3892/or.2020.7461.


Chromosomal Alterations and Gene Expression Changes Associated with the Progression of Leukoplakia to Advanced Gingivobuccal Cancer.

Bhosale P, Cristea S, Ambatipudi S, Desai R, Kumar R, Patil A Transl Oncol. 2017; 10(3):396-409.

PMID: 28433800 PMC: 5403767. DOI: 10.1016/j.tranon.2017.03.008.


Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma.

Nema R, Vishwakarma S, Agarwal R, Panday R, Kumar A Onco Targets Ther. 2016; 9:3269-80.

PMID: 27330306 PMC: 4898435. DOI: 10.2147/OTT.S99989.


Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.

Towle R, Tsui I, Zhu Y, MacLellan S, Poh C, Garnis C Cancer Med. 2014; 3(5):1170-84.

PMID: 25060540 PMC: 4302668. DOI: 10.1002/cam4.307.


References
1.
Mao L, Hong W, Papadimitrakopoulou V . Focus on head and neck cancer. Cancer Cell. 2004; 5(4):311-6. DOI: 10.1016/s1535-6108(04)00090-x. View

2.
Rosin M, Lam W, Poh C, Le N, Li R, Zeng T . 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res. 2002; 62(22):6447-50. View

3.
Wong K, deLeeuw R, Dosanjh N, Kimm L, Cheng Z, Horsman D . A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet. 2006; 80(1):91-104. PMC: 1785303. DOI: 10.1086/510560. View

4.
Bierie B, Moses H . Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer. 2006; 6(7):506-20. DOI: 10.1038/nrc1926. View

5.
Jong K, Marchiori E, Meijer G, Vaart A, Ylstra B . Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics. 2004; 20(18):3636-7. DOI: 10.1093/bioinformatics/bth355. View